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Summary: Twenty out-patient and twenty in-patient adult Nigerian type II diabetics and twenty healthy subjects
matched for sex, age and weight, were studied at Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Mean total cholesterol and fasting blood glucose concentrations were higher in the diabetics. The out-patients had
significantly higher total cholesterol and fasting blood glucose values than their in-patient counterparts. The possible
cardiovascular risk of the raised cholesterol level in the diabetics was discussed. We recommend that for effective
management of diabetic patients, periodic measurement of cholesterol level is necessary. An integrated enlighten-
ment programme to acquaint the out-patients with the health benefits of dietary and drug compliance and occasional
hospitalisation for better monitoring would be desirable.
Introduction
In diabetic patients, macrovascular disease accounts for
the majority of all deaths, mainly in the form of cardio-
vascular disease (1). Irrespective of the well known
heterogeneity in the aetiology of diabetes, the propensity
of macrovascular complication is not restricted to any
particular type of diabetes (2, 3). Furthermore, clinically
significant atherosclerotic lesions were found to be un-
associated with the duration or severity of overt diabe-
tes; they were rather a feature of individuals with rela-
tively mild diabetes (4—6). Meanwhile, clinical and his-
topathological evidence of accelerated atherosclerosis
has been documented in insulin-dependent diabetics (7).
Hyperlipidaemia is a common complication among dia-
betics. The most commonly known lipid abnormality in
diabetics is hypertriglyceridaemia, and not an increase
in total cholesterol (8—10). However, elevation of the
total cholesterol level (an independent cardiovascular
risk factor) (11) has been reported in certain populations
of patients (12-14).
In the present study, our subjects were drawn from a
sub-urban commercial area. We determined, for the first
time, the serum cholesterol levels iri the diabetic patients
from this community, and excluded the possible influ-
ence of other risk factors such as obesity, smoking and
alcoholism through interview assessment. In addition,
this study is expected to provide data that would
discriminate between the in-patient and out-patient dia-
betics with respect to the level of the complicating
factor, hypercholesterolaemia; this will form a basis for
the better management and/or follow-up of patients by
clinicians.
Patients, Materials and Methods
Selection of patients and control subjects
Forty diabetic patients of both sexes, aged 40.0 ±3.2 years (mean
± SEM) and twenty apparently healthy subjects matched for age
and sex were selected for this study at Nnamdi Azikiwe University
Teaching Hospital, Nnewi, Nigeria. The diabetic patients consisted
of twenty out-patients and twenty in-patients (10 males and 10
females in each case). The diagnosis of diabetes was established
by clinical examinations and laboratory analyses of two hours post-
prandial blood glucose level, oral glucose tolerance test with 75 g
glucose load and fasting blood glucose levels. The patients were
type II diabetics (non-insulin-dependent diabetes mellitus), and the
duration of diabetes ranged between 1 and 3 years; in all patients,
diabetes onset occurred in adulthood. The out-patients were treated
with Glipizide (GLUCOTROL), a member of the sulfonylurea
group of hypoglycaemic agents, in doses of 5 and 10 mg tablets
daily plus a recommended diabetic diet (same diet as given to the
in-patients in the hospital). Patients were monitored every fortnight
in the ambulatory state. The in-patients were hospitalised for 2-4
weeks and treated with Glipizide like their out-patient counterparts
plus the compulsory diabetic diet served in the hospital, which con-
tained high levels of plant protein (beans), plantain and vegetables,
and low carbohydrate.
The control subjects consisted of ten male and ten female staff
volunteers from our teaching hospital and the local government
secretariat office. The patients and controls were all Nigerians and
oral and written consent were given before selection into the study.
Routine medical examinations and interviews were carried out in
order to eliminate the presence of other diseases and risk factors
in all the patients and controls. The patients (diastolic blood pres-
sure = 81 ±0.8 mmHg mean ± SEM) and controls (diastolic
blood pressure = 80 ± 0.9 mm Hg mean ± SEM) were non-hyper-
tensives as confirmed by the World Health Organisation criteria
for mild to moderate hypertension (15), non-obese, non-smokers
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and non-consumers of alcoholic beverages. The female patients and
controls were neither pregnant nor lactating, and they were not on
oral contraceptives.
Measurement of physical variables, sample collection,
glucose and cholesterol assays
Following selection into the study, the weight of each subject was
taken with an electronic weighing scale. Level of obesity was de-
termined in each patient or control by body mass index. Body mass
index was calculated as weight/height2 (kg/m2), and subjects with
body mass index values of above 25 were regarded as obese (16).
A standard format was adopted to measure cigarette smoking and
alcohol consumption.
Venous blood (10 ml) was withdrawn from each subject (both pa-
tients and controls) after an overnight fast of 10-12 hours. An
aliquot of 2 ml for glucose analysis was collected into a container
with sodium fluoride as the anticoagulant. The remaining 8 ml in-
tended for cholesterol analysis was collected into a plain bottle and
allowed to clot; thereafter the serum was separated for cholesterol
assay. Fasting blood glucose was determined by the method of
Trinder (17). Plasma cholesterol was determined by the modified
Liebermann-Burchard reaction as described by Searcy & Berquist
(18). The fasting blood glucose and total cholesterol assays were
standardised and quality controlled by using pooled sera and com-
mercial Wellcomtrol one and two reagents of known values. The
patients and the controls were of the same socio-economic back-
ground.
Statistical analysis
Analysis of variance was used to assess the variability between and
within the in-patients and out-patients, and the control subjects.
The statistical significance of differences between the mean values
of fasting blood glucose and cholesterol for the in-patient and out-
patient diabetics and the control subjects were determined by a
two-tailed Student t-test.
Results
As shown in figure la, the out-patient (P < 0.001) and
in-patient (P < 0.01) diabetics had significantly higher
fasting blood glucose concentrations when compared
with the control subjects. The mean fasting blood glu-
cose concentration of the out-patient was also signifi-
cantly higher (P < 0.05) than that of the in-patient dia-
betics.
Similarly, the mean total cholesterol concentrations of
the out-patient and in-patient diabetics were significantly
higher (P < 0.001 and P < 0.05 r respectively) when
compared with the corresponding control values (fig.
Ib). The difference in the mean total cholesterol value
between the out-patient and in-patient diabetics, was
also significant (P < 0.05).
Discussion
The observed increase in the fasting blood glucose in
the diabetics was expected and the significant rise in
total cholesterol concentration in the diabetic patients in
this study is consistent with the findings reported by
previous workers (12—14), but disagrees with others
(8—9) who reported hypertriglyceridaemia as the main
lipid abnormality in their diabetic patients. Furthermore,
we observed that the mean total cholesterol level of our
out-patients was significantly higher than the value for
the in-patient diabetics. The mean total cholesterol level
(7.3 ±1.6 mmol/1) of the out-patient diabetics was al-
most two-fold higher than that of the control subjects
(4.8 ± 0.68 mmol/1), and quite above the normal refer-
ence range for total cholesterol (2.5—5.7 mmol/1) in the
Nigerian population. The mean total cholesterol level of
(5.5 ± 0.96 mmol/1) for the in-patients, though signifi-
cantly higher than that of control subjects, falls within
the upper limits of the normal reference range for total
cholesterol of the entire Nigerian population. Raised
cholesterol has long been recognised as a potent risk
factor for the development of coronary heart disease
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Fig. la Comparison of fasting blood glucose levels between dia-
betic patients and healthy subjects,
control vs diabetic out-patients = P < 0.001;
control vs diabetic in-patients = P < 0.01;
diabetic out-patients vs diabetic in-patients = P < 0.05.
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Fig. Ib comparison of total cholesterol levels between diabetic
patients and healthy subjects.
control vs diabetic out-patients = P < 0.001;
control vs diabetic in-patients = P < 0.05;
diabetic out-patients vs diabetic in-patients = P < 0.05.
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(13-14, 19). Thus, it is pertinent to say that all the dia-
betic patients in this study were exposed to a higher risk
of coronary heart disease viz-a-viz the co-existence of
hyperglycaemia and hypercholesterolaemia. Meanwhile,
the risk of coronary heart disease was even higher in
the out-patient diabetics, thereby making their condition
more precarious. It was not surprising that the blood
glucose level of the out-patients was poorly controlled,
because these patients may have defaulted in the dietary
and drug prescriptions, unlike their in-patient counter-
parts who were under close monitoring by the physician.
The out-patients in their homes may have been enjoying
the normal Nigerian diet which consists mainly of high
carbohydrate, low protein and vegetable meal, and this
differs a little in terms of percentage micronutrients
from the recommended diabetic diet (served in the hos-
pital) as described earlier in the text. Most of the patients
studied had a low level of education (mainly primary
school level); this factor compounded their problem be-
cause these patients could not actually appreciate the
health hazards associated with non-compliance with
their diet and antidiabetic drugs. It is possible that non-
regulation of dietary fat and carbohydrate intake may
have contributed to the higher levels of total cholesterol
in the out-patients (20). Thus, we recommend that for
effective management of diabetic patients with a back-
ground similar to the one described here, periodic mea-
surement of cholesterol level is necessary. An integrated
programme to educate the patients about the health ben-
efits of compliance with their dietary and drug therapies
will be desirable. Occasionally, the out-patients may be
required to undergo hospital admission for better moni-
toring and management.
In general, these findings should assist diabetologists
and other physicians in the effective management of dia-
betic patients with similar backgrounds to those in this
study.
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